Showing results (721-730 of 977) with videos related to

Sort By:
Pageof 98
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
Latent Cytomegalovirus Infection in Rheumatoid Arthritis and Increased Frequencies of Cytolytic LIR-1+CD8+ T CellsKathrin Rothe, Dagmar Quandt, Kristin Schubert, et al.
Anticancer Research|March 16, 2016
Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in GlioblastomaJudith Proske, Lisa Walter, Elisabeth Bumes, et al.
Cancer Medicine|December 11, 2019
Autoimmune diseases and immunosuppressive therapy in relation to the risk of gliomaTareq M Anssar, Michael F Leitzmann, Ralf A Linker, et al.
The New England Journal of Medicine|May 20, 2005
Cystatin C and the risk of death and cardiovascular events among elderly personsMichael G Shlipak, Mark J Sarnak, Ronit Katz, et al.
Cancer Research|June 17, 2006
Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunityHåkan Norell, Mattias Carlsten, Tomas Ohlum, et al.
Molecular Cancer Research : MCR|September 13, 2013
HER-2/neu mediates oncogenic transformation via altered CREB expression and functionAndré Steven, Sandra Leisz, Chiara Massa, et al.
JAMA|December 17, 2002
Risk of hip fracture among dialysis and renal transplant recipientsAdrianne M Ball, Daniel L Gillen, Donald Sherrard, et al.
Archives of Internal Medicine|June 24, 2009
The frequency of hyperkalemia and its significance in chronic kidney diseaseLisa M Einhorn, Min Zhan, Van Doren Hsu, et al.
Proteomics|May 20, 2011
Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cellsBarbara Seliger, Sven P Dressler, Chiara Massa, et al.
Cancer Medicine|December 2, 2024
Targeted agents in patients with progressive glioblastoma-A systematic meta-analysis of randomized clinical trialsFranziska Maria Ippen, Angelika Scherm, Tobias Kessler, et al.
Pageof 98